The significance of lipid droplets in lipid metabolism, cell signaling, and regulating longevity is increasingly recognized, yet the lipid droplet's unique properties and architecture make it difficult to size and study using conventional methods. To begin to address this issue, we demonstrate the capabilities of nanoparticle tracking analysis (NTA) for sizing of lipid droplets. NTA was found to be adequate to assess lipid droplet stability over time, indicating that lipid droplet preparations are stable for up to 24 h. NTA had the ability to compare the size distributions of lipid droplets from adult and geriatric mouse liver tissue, suggesting an age-related decrease in lipid droplet size. This is the first report on the use of NTA to size intracellular organelles.
Introduction
Intracellular lipid droplets, composed of a neutral lipid core surrounded by a phospholipid monolayer, are found in most cell types. These dynamic organelles play roles in many cellular processes, including lipid metabolism, cell signaling, immune function, membrane trafficking, and regulation of longevity [1, 2] . Larger triacylglycerol -rich lipid droplets (10-200 μm diameter) are present in adipocytes [3, 4] , whereas smaller lipid droplets (1 μm diameter or less) enriched in cholesteryl esters exist in brown adipose tissue, liver, muscle, heart, and connective tissues [5] . The accumulation of excess lipids in lipid droplets is associated with a multitude of lipid storage-associated disorders, including lipodystrophies, obesity, cachexia, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD) [6] . In these disease states, the accumulation of lipid droplets is both a hallmark and etiological factor in disease development and progression [7, 8] . Although numerous studies have defined the molecular and physiological changes that occur in the progression of these diseases, techniques to study individual lipid droplets are limited. To begin to address this, it is imperative to investigate new methods that enable the measurement of individual lipid droplets.
The most commonly employed method of measuring lipid droplet size is confocal fluorescent microscopy [9] [10] [11] . Lipid droplets in cells and tissue sections are visualized by a number of commercially available lipophilic dyes [12] [13] [14] [15] and the area and number of lipid droplets in the field of view are quantified using image analysis software [16] . Lipophilic dyes with improved selectivity, improved photostability, and reduced cytotoxicity have been developed in recent years [17, 18] . Measuring the size of individual lipid droplets from microscopy images is not high-throughput and microscopy experiments with lipophilic dyes must be interpreted with caution, as fluorescence signal is influenced by variations in the cellular distribution of the dye and its incorporation into other lipid rich structures. Colocalization experiments with bonafide lipid droplet markers are required for correct identification of lipid droplets, but often these lipid droplet proteins do not coat all lipid droplets. Further, in order to evaluate lipid droplets in tissues by microscopy, the sample of interest must be embedded, sectioned, and stained prior to visualization [14] , requiring a major time investment. Recently developed anti-Stokes Raman Scattering (CARS) [19] and Stimulated Raman Scattering (SERS) [20] imaging methods have been used to size lipid droplets in cells. While these label-free methods represent an improvement over fluorescent microscopy, a sophisticated instrumental setup is required and these methods are further limited by the relatively low signal intensity and long acquisition time required for Raman-based imaging techniques. Recently, three-dimensional quantitative phase imaging of lipid droplets in hepatocytes was reported [21] , but this method also requires a sophisticated instrumental setup and so far has only been applied to individual cells. Despite existing imaging methods for measuring lipid droplet size in cells and tissues, a label-free method based on individual lipid droplet size measurements would reduce the bias introduced by limited throughput, eliminate the need for lipophilic dyes and complex instrumental setup, and allow the lipid droplets to be recovered for downstream analysis.
Flow cytometry and capillary cytometry are well-defined methods for determining heterogeneity among individual organelles [22] [23] [24] . To our knowledge, there has been no report of flow cytometry of individual lipid droplets, possibly due to their unique physiochemical properties, including low specific gravity and tendency to adsorb to surfaces. Size distribution of individual lipid droplets isolated from cells and tissues has been measured by dynamic light scattering (DLS) [9] , but this method is an ensemble technique based on the assumption that dispersed particles are uniform in composition, making it inappropriate for heterogeneous biological samples. Furthermore, DLS measurements are highly influenced by the presence of large particles or aggregates in the particle suspension.
Nanoparticle tracking analysis (NTA) is a single-particle measurement technique, as opposed to the ensemble approach of DLS, enabling it to measure individual nanoparticle size and concentration in a given sample [25] . In NTA, a particle dispersion is placed within an optical cell and irradiated with an intense laser source. The light scattered by individual particles within the cell is collected using a microscope objective and recorded with a camera. While the particles are too small to image optically, their scattered light reveals the position and Brownian motion of each particle in the field of view. The recorded motion is analyzed to derive the two-dimensional diffusion constant of each particle, which is then used to calculate the particle's sphere equivalent hydrodynamic radius. Unlike DLS, NTA provides a direct number-weighted particle size distribution and increased size resolution for non-uniform samples. NTA has been used previously to determine the size and concentration of biological particles, including exosomes [26] [27] [28] [29] , virus particles [30] , and gold nanoparticle-protein conjugates [31] , but has never been used to measure the size of lipid droplets.
This article introduces a new method for monitoring lipid droplet size in tissues using NTA. Analysis of isolated lipid droplet dispersions via NTA takes less than 10 min, and can be applied to lipid droplets isolated from any tissue or cell of interest. Further, NTA is nondestructive, and the lipid droplets can be recovered after measurement for downstream analysis. We assessed the ability of a Nanosight LM-10 instrument to measure size and determine its suitability to measure lipid droplets isolated from mouse liver. We also applied the method to monitor lipid droplet preparation stability over time and measure the lipid droplet size distributions in adult and geriatric mice. This work represents the first size measurements of isolated lipid droplets and intracellular organelles. 
Lipid droplet isolation from mouse liver
Lipid droplets were prepared from the livers of C57BL/6 female mice, as described previously [32, 33] . Mice were euthanized by intraperitoneal injection of pentobarbital (200 mg/ Kg) and the liver was excised. All isolation steps were done at 4°C. The liver was weighed and minced in a petri dish, using a flat razor blade, into small (1 mm) pieces and resuspended in 3 mL of Buffer H. The liver homogenate was transferred into a nitrogen cavitation chamber and charged to 200 psi. After 15 min on ice, the cell lysate was released from the nitrogen cavitation chamber into a 50 mL conical tube and centrifuged at 1000 g for 10 min. The post-nuclear supernatant was loaded onto a sucrose step gradient (4 mL 35% sucrose/ Buffer A, 4 mL 25% sucrose/Buffer A), and centrifuged at 36,000 rpm in a Beckman SW 41 swinging bucket rotor for 4 h. The lipid droplet fraction appeared as white film at the top of the tube, which was removed with a Pasteur pipette. The lipid droplets suspension was mixed by pipetting and diluted 1:90 in Buffer H prior to loading into the Nanosight LM-10 analysis chamber.
For stability measurements, lipid droplets were isolated from a 35-wk-old C57BL/6 mouse. The lipid droplet sample was measured initially after isolation using NTA (day 0). The lipid droplet suspension was stored in an microcentrifuge tube on a rotator in a 4°C cold room. The lipid droplet suspension was sampled at 24 h, 48 h, and 1 wk later (samples designated day 1, day 2, and day 7). To investigate the differences in lipid droplet size distributions between geriatric mice and adult mice, lipid droplets were isolated from n = 3 livers from geriatric mice and n = 3 livers from adult mice prior to NTA. Mice in the adult group were~35 wk and mice in the geriatric group were~115 wk.
Nanoparticle tracking analysis
The size distributions of lipid droplets, along with those of particle size standards, were measured using a Nanosight LM-10 Nanoparticle Tracking Analyzer (Malvern, Salisbury, UK). The instrument was equipped with a 405 nm laser and a high sensitivity CMOS camera. Quadruplicate videos of each sample were captured for 60 s in static mode. The frame rate was 25 frames per s, and up to 1500 frames were captured per video. The chamber temperature was controlled at 25°C, camera gain was set to Bautomatic^, and the viscosity was set to Bwater^. Videos were analyzed with NTA 3.2 Dev Build 3.2.16 software to yield a number-weighted size distribution in the size range of interest (between about 30 and 1000 nm), along with several statistical measures of that distribution, including its median, mean, and standard deviation. To verify particle size accuracy, polystyrene latex nanosphere standards were also measured at three sizes: 203 nm ± 6 nm (#3K-200), 102 nm ± 8 nm (#3K-100), and 31 nm (#3030A). All particle standards and their specifications (when available) were obtained from Thermo Fisher Scientific (Waltham, MA, USA). Dilutions were made in sterile filtered distilled water.
Data analysis
Each particle's motion is tracked individually from frame to frame during the 60 s measurement period. The NTA software examines each track to determine if it meets the quality criterion, i.e., staying within the field of view for a sufficient number of frames to accurately reconstruct the particle motion. Using the subset of the raw track data that meets this criterion, the NTA software determines the particle's diffusion constant (D, m 2 /s) from Brownian motion. The diffusion coefficient is subsequently used to calculate a sphere equivalent hydrodynamic radius (r h ), through the Stokes-Einstein relationship (Eq. 1) ), T is temperature (25°C), and η is viscosity of water (0.89 N s/m 2 at 25°C). While Brownian motion occurs in three dimensions, the Nanosight observes the individual particles in two dimensions and the NTA software derives D using the equation below (Eq. 2)
where t is time and x and y are distance on two orthogonal axes.
As diffusion is isotropic in space and occurs independently in all directions, 2D measurement of movement is an accurate representation of 3D Brownian motion [34, 35] . Size distribution (number weighting), size percentiles, summary statistics, and videos were exported from NTA 3.2. Raw lipid droplet size measurements were corrected using particle standard data via the procedure described below. The % error (e) in NTA measurement was calculated using Eq. 3:
where μ is the mean particle size reported by TEM, and x is is the mean size of the particle standard reported by NTA. The % error e at each lipid droplet size was calculated from the particle standard measurements using the approach described in the Electronic Supplementary Material (ESM) in Section BSupplementary Data Analysis^. As each error in measurement was in the positive direction, a correction factor for each size was calculated using Eq. 4:
The corrected LD particle size (LD 1 ) was calculated using Eq. 5.
where LD 0 is the observed LD particle size and c is the correction factor. 
Results and discussion

Figures of Merit
In order to evaluate the suitability of the Nanosight LM-10 in lipid droplet analysis, we assessed the ability to determine size accurately over size ranges expected to be found in lipid droplets. According to the manufacturer's specifications, the Nanosight LM-10 is suitable to measure concentrations of 10 6 to~10 9 particles/mL in the size range from 10 nm to 2000 nm. These values are dependent on the nature of the particles being measured. We selected polystyrene latex nanospheres (refractive index (1.615) [36] ) over metallic nanoparticles (refractive index > 2.0) because the former's refractive index is similar to that of individual organelles, such as mitochondria (1.41) [37] , and triglycerides (1.43-1.48) [38] , the main component of lipid droplets.
We used polystyrene latex nanospheres of different sizes to determine the size accuracy of measuring biological particles on the Nanosight LM-10 ( Table 1) . The expected mean size of the smallest polystyrene latex nanoparticles used in this study, determined by the manufacturer using DLS, was 31 nm. At a particle concentration of (1.66 ± 0.08 ) × 10 9 particles/mL, the mean particle size as measured by NTA was 38 ± 1 nm (±SEM). The size distributions of the particle standards obtained via NTA can be visualized in a histogram, Fig. 1a . We sized the nominal 31 nm particles by TEM (ESM Fig. S1 ) to provide individual particle size measurements to compare with NTA measurement. TEM analysis indicated that the mean diameter of the 31 nm standards was 25 nm ± 5 nm (±SEM). Therefore, at a 25 nm polystyrene nanosphere size, NTA reports a 52% higher mean particle size than TEM. We subsequently measured the 102 nm ± 8 nm (±SEM) and 203 nm ± 5 nm (±SEM) particle standards by NTA (Fig. 1b  and c) . The Nanosight reported a 5% higher mean particle size than TEM at 102 nm, and was in agreement with TEM measurement at 203 nm. We used the measurement of these three standards to correct the sizes of lipid droplets reported by NTA. The correction factor was different for each size and was calculated using Eqs. 3 and 4.
We also measured a dilution series of the 203 nm polystyrene latex nanospheres to establish a low concentration limit for biological particles on the Nanosight LM-10. The result from measurements of the dilution series is summarized in Table 2 . At the highest particle concentration measured, 1.59 × 10 9 particles/mL, the mean particle size was 203 ± 1 nm (±SEM). At the lowest particle concentration measured, (1.43 ± 0.66) × 10 7 particles/mL, the mean particle size was 174 ± 24 nm. The tabulated data suggest that NTA decreases in measurement accuracy at concentrations below (2.58 ± 0.18) × 10 8 particles/mL. While the manufacturer indicates the Nanosight LM-10 can accurately size measure~10 6 to~10 9 particles/mL, our data suggests that NTA is only appropriate for biological particle concentrations near the high end of the manufacturer's recommended range.
Nanoparticle tracking analysis of individual lipid droplets
The next focus of this study was to determine the suitability of NTA for measuring the size distributions of lipid droplets. Prior work demonstrated the use of NTA to measure size distributions of biological particles, most notably exosomes (20-100 nm in size) [26] [27] [28] [29] . It is unclear whether these prior studies used size standards to assess and correct for systematic sizing errors. Furthermore, NTA has never been applied to lipid droplets. Lipid droplets were isolated from mouse liver tissue and the purity of the cellular fractions were validated by Western blot (ESM Fig. S2 ). In the Nanosight chamber, lipid droplets act as from which their individual motion paths were recorded wth a CMOS video camera operating at 25 frames per s. The diameter of the individual particles was calculated from their diffusion constant by the Nanosight NTA software using Eqs. 1 and 2 as described above, and corrected using the standard particle measurements with Eqs. 3 and 4.
A histogram was used to visualize the corrected size distribution of lipid droplets isolated from mouse liver tissue (Fig.  2 ). The mean corrected particle size was 168 ± 2 nm (mean ±SEM, n = 5 technical replicates). In non-adipocytes, lipid droplets do not exceed 1 μm in diameter under basal conditions [39] . In lipid loaded conditons or disease models, nonadipocyte lipid droplets grow in size (8-20 μm) and usually form heterogenous populations varying in size and lipid 
Lipid droplet stability analysis
To investigate the stability of lipid droplets during storage, we compared the individual lipid droplet size distributions resulting from uncorrected measurements of a single preparation of lipid droplets over the course of 1 wk. The mean lipid droplet size and mean lipid droplet concentration for each day are summarized in Table 3 . The shift in distribution shape apparent on each day can be further appreciated by histograms (ESM Fig. S3) . One way ANOVA analysis indicated statistically significant differences in mean LD size (ESM Table S1A ) and mean LD concentration (ESM Table S2A ) sampled on all 4 day. This suggests that the lipid droplet preparation was not stable over the 1-wk period. Tukey post-hoc testing indicated that mean LD size was not significantly different from day 0 to day 1 or day 2 (ESM Table S1A ). Similary, Tukey post-hoc testing indicated only mean LD concentration day 0 and day 1 (ESM Table S1B ) are not significantly different. Thus, LD preparations were stable in terms of size distribution and concentration for up to 1 day.
We chose to use QQ plots to visualize changes among LD size distributions (Fig. 3) . The percentiles of day 1 and day 2 (y axis) were visually similar to day 0, whereas the percentiles of day 7 shifted in the positive y-direction. If two distributions are similar in shape, a QQ plot comparing them approaches an X = Y line. Thus, the slope of the linear fit of their QQ plot will be~1. To investigate if this was the case, we applied linear regression analysis and made pairwise comparisons of the slopes. The distributions between slopes were not statistically significant for day 1 versus day 0. The statistical significant difference between the day 2 versus day 0 slope is indicative of changes in the lipid droplet size distribution. Not surprisingly, the comparison of day 7 versus day 0 displayed the largest changes and cannot be fit to a linear model. Thus, based on the ANOVA, post-hoc Tukey, QQ plots, and linear regression analysis, lipid droplets maintain their stability for 24 h. These results suggest size analysis of isolated lipid Fig. 2 Mouse liver lipid droplet size distribution determined by NTA. The particle concentration was (2.13 ±0.14) × 10 9 particles/mL (mean ±SEM, n = 5 technical replicates). Shaded area of histogram represents particle density (average ±SEM, n = 5 technical replicates). Horizontal error bars represent size error (±SEM, n = 5 technical replicates) at percentiles ranging from 5 th to 95 th percentile at 5% increments Lipid droplet size analysis in adult and geriatric mice
The population of lipid droplets in any given cell is size heterogeneous, and evidence suggests that LDs of various sizes differ in in lipid composition and the recruitment of cytosolic proteins [42] . Lipid droplet size changes resulting from different membrane composition and protein recruitment have been reported previously [43, 44] , but have never been described in a comparative aging study. Aging is associated with lipid accumulation in multiple tissues, including the liver [45, 46] , but the effect of age-related lipid accumulation on lipid droplet size or number has not yet been investigated. This work represents the first measurements of lipid droplet size distribution in geriatric mice.
The mean corrected LD size is summarized in Table 4 . It indicates a larger variation in mean lipid droplet size among the geriatric mice, as expected. The distributions in corrected lipid droplet sizes were further compared using a QQ plot (Fig. 4a) . The general trend of the geriatric quantiles was a shift towards the x-axis from the adult quantiles, indicative of a smaller size. Furthermore, the clear deviation from the 5 th -65 th percentiles suggested an increased abundance of smaller [47] lipid droplet sizes. The uniqueness in the distribution of each aging mouse is captured by plotting the lipid droplet size distribution from each geriatric mouse versus the average lipid droplet size distribution from the adult mice (ESM Fig. S5 ) as well as the respective relative variation of size distributions (ESM Fig. S6) .
A statistical significance profile was necessary to ascertain the average size distribution disparities that exist in the geriatric mice compared with the adult mice (Fig. 4b) . Statistically significant (p < 0.05) differences existed in all regions except for the last 10% of the distribution (representing 90 th -99 th percentiles, 302 nm-528 nm for geriatric mice and 322-619 nm for adult mice). The most significant differences were at first 10% (representing 1 st -9 th percentiles, 14-19 nm for geriatric mice and 86-109 nm for adult mice), representing the smallest lipid droplets. Thus, geriatric mice have a statistically significant different distribution of lipid droplet sizes relative to the adult mice, characterized by lipid droplets of smaller size.
Conclusion
While NTA has been successfully applied to exosomes [26] [27] [28] [29] , virus particles [30] , and gold nanoparticle-protein conjugates [31] , here we introduce NTA for the size measurements of lipid droplets isolated from tissues. To our knowledge, lipid droplets have not been sized in isolation. This method is capable of measuring the size distributions of lipid droplets from any tissue or cell type amenable to lipid droplet isolation, including human tissue biopsies. The complete procedure from tissue excision, organelle isolation, and NTA analysis can be completed in approximately 6 h, and the lipid droplet sample can be recovered and used in downstream analysis. This represents a vast improvement over time consuming and low throughput imaging based lipid droplet size measurements.
Funding This work was supported by NIH AG020866. KAM acknowledges support through a University of Minnesota Doctoral Dissertation Fellowship and National Institutes of Health (NIH) AG029796. CPN acknowledges support from NIH DK007203. NML acknowledges support from NIH GM008700. DGM acknowledges support from NIH DK114401 and NIH AG055452. A portion of this work was carried out in the Minnesota Nano Center, which receives partial support from the National Science Foundation (NSF) through the NNCI program. A portion of this work was carried out in the Characterization Facility, University of Minnesota, which receives partial support from NSF through the MRSEC program.
Compliance with Ethical Standards
All mice were housed in a designated clean facility and treated in accordance with protocols approved by the University of Minnesota Institutional Animal Care and Use Committee.
